These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Effects of the nicotinic ester of 7(2-hydroxyethyl)-theophylline on peripheral arteriopathies in the aged]. Bandinelli G, De Mauro G, Provvedi D, Bellini PG, Rubegni M. Cardiol Prat; 1973; 24(3):275-80. PubMed ID: 4779825 [No Abstract] [Full Text] [Related]
12. [Analgesic therapy of arteriopathies]. Rossano C, Testasecca D, Giuliano F, De Luca PF. Minerva Med; 1974 Mar 31; 65(24):1286-9. PubMed ID: 4133958 [No Abstract] [Full Text] [Related]
13. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders]. Weber G, Vogel A. Dermatol Wochenschr; 1967 Nov 18; 153(46):1278-82. PubMed ID: 5588908 [No Abstract] [Full Text] [Related]
14. [Effect of bencyclane in obliterative arterial diseases]. Kusztos D. Arzneimittelforschung; 1970 Oct 18; 20(10):Suppl 10a:1419+. PubMed ID: 5536658 [No Abstract] [Full Text] [Related]
15. [Modification of the vascular changes of the ocular fundus by xantinol nicotinate]. von Grósz I, Födö V. Med Welt; 1969 Aug 30; 35():1916-7. PubMed ID: 5809867 [No Abstract] [Full Text] [Related]
16. [Xanthinol-nicotinate (complamine)]. Cas Lek Cesk; 1968 Aug 30; 107(51):1567-8. PubMed ID: 5700857 [No Abstract] [Full Text] [Related]
17. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy]. Cascio F. Minerva Cardioangiol; 1973 Nov 30; 21(11):715-31. PubMed ID: 4776567 [No Abstract] [Full Text] [Related]